|
Mr. Savas has served as Chairman and Chief Executive Officer of Alseres Pharmaceuticals, Inc. since September 2004. Prior to joining ALSE, Mr. Savas was Chairman, President, and Chief Executive Officer of Aderis Pharmaceuticals, a privately held biopharmaceutical company headquartered in Hopkinton, MA. While at Aderis, Mr. Savas undertook and completed a $45 million private placement at nearly double the valuation of the prior venture round; strengthened the Board of Directors, Scientific Advisory Board and management; culled out dead-end programs; and revitalized and expanded corporate partnerships. Before joining Aderis, Mr. Savas was Chairman, President and CEO of Unisyn Technologies, a company he refinanced, repositioned and subsequently merged with Cellex Biosciences. Before Unisyn, Mr. Savas served as Senior Vice President of Zymark Corporation, a laboratory automation company; Chairman, President and CEO of Xydex Corporation, a company he founded to in-license, develop, and commercialize novel separations technology, which he subsequently sold to Genex Corporation. He was also Vice President and General Manager of Business Operations of the Continental Water Systems and the Waters Associates Divisions of Millipore Corporation. Mr. Savas is currently Chairman of Amphora Discovery Corporation. Mr. Savas earned his BA in chemistry from Syracuse University. | 